Genomics Market To Show Higher CAGR Globally Till 2024 | Hexa Research

1
Your Catalyst To a Lucrative Business Genomics
Market Share, Size, Analysis, Growth, Regional
Outlook, Competitive Scenario and Forecasts to
2024 Hexa Research
" Focusing on steps to implement it and rising
genome profiling technologies are expected to
grow the genomics market at the rapid speed."
The global Genomics Market is propelled by the
introduction of novel technologies that utilize
genomic information in disease research. It
helps researchers comprehend the genetic bases of
drug responses diseases. Favorable government
reimbursement policies coupled with high
incidence of lifestyle diseases, such as
diabetes cancer and are key industry drivers.
Popularity of genome profiling technologies and
widespread use of innovative genomics tools
techniques can fuel market demand over the
forecast period (2016 - 2024). Genomics is that
aspect of biology that deals with bioinformatics,
DNA, and DNA sequencing to analyze, assemble,
and sequence the structure function of genomes.
Genomes refer to the entire DNA set in a single
cell of an organism. The worldwide Genomics
Market is systematically categorized on the basis
of products, applications, technologies, and
regions. Instruments, services, and consumables
are the three key product segments. With a
nearly 60 share, consumables dominated the
industry in 2013. This segment is expected to
grow at a CAGR surpassing 11 during the
forecast period. Popularity of genomic testing in
a host of commercial applications is a key
driver of this segment. Browse Details of Report
_at_ https//www.hexaresearch.com/research-report/ge
nomics-industry
2
Your Catalyst To a Lucrative Business On the
basis of applications, the global genomics
industry is divided into academic research, drug
discovery, diagnostics, personalized medicine,
and others. Diagnostics held the highest mar ket
share in 2013. Preference for molecular
diagnostics tests and awareness among medical
practitioners about the advantages of genetic -
based diagnostics are factors that propel this
segment. It is expected that personalized
medicine will register a high growth rate
throughout the forecast period. Treatment
optimization, affordable treatments, patient
compliance, early disease prognosis, and drug
safety are vital drivers of this segment. North
America emerged a global leader in the market
for personalized medicine in 2013. This was due
to progress in the world of genetics and robust
technological developments. As per
technologies, the industry is segmented as DNA
microarray, nucleic acid extraction
purification, PCR (polymerase chain reaction),
and DNA sequencing. PCR led the market in 2013
due to factors, such as RD in genomics
proteomics, encouraging government policies on
RD funding, and technological advancements.
Ongoing industry trends suggest that the nucleic
acid extraction purification segme nt may grow
at a CAGR exceeding 10 till 2024. Europe, Asia
Pacific, North America, and Rest of the World are
the four regional segments of the global
Genomics Industry. Prevalence of cardiovascular
genetic disorders and high investments in
genomics proteomics drive the Europe genomics
market. This region held the largest industry
share in 2013. However, volatile economic
conditions and uneven reimbursement policies may
hamper regional growth in the forthcoming
years. Asia Pacific is expected to grow rapidly
over the forecast period because of widespread
adoption of genomics techniques in emerging
countries, such as China and India. These regions
utilize genomics technologies to diagnose
treat diseases, like cancer and diabetes. Other
factors that fu el the Asia Pacific region are
surging medical expenditure, high disposable
incomes, and better healthcare infrastructure.
Key players in the global genomics market are
Life Technologies, Roche Diagnostics, GE
Healthcare, Agilent Technologies, and
Cepheid. Researchers have developed a microscope
that uses a cell phone camera for detecting
fluorescent components of DNA sequencing
responses in tissues cells. This special device
can identify point mutations in KRAS genes. The
KRAS gene is found in more than thirty percent of
colon cancers. A number of sequencing techniques
are used to fluorescently label amplify copies
of the target DNA transcript or sequence. Browse
Related Category Market Reports _at_
https//www.hexaresearch.com/research-category/bio
technology-industry
3

• Your Catalyst To a Lucrative Business
• Table of Content of Genomics Market Chapter 1.
  Executive Summary
• 1.1. Genomics - Industry Summary and Critical
  Success Factors (CSFs)
• Chapter 2. Genomics Industry Outlook
• Market Segmentation
• Market Size and Growth Prospects
• Genomics - Market dynamics
• Market Driver Analysis
• Market Restraint Analysis
• Key Opportunities Prioritized
• Genomics - PESTEL Analysis
• Chapter 3. Genomics Market Product Outlook
• Genomics Market Revenue Share by Product, 2016
  2024
• Genomics Instruments Market
• Genomics Instruments Market, 2016 - 2024 (USD
  Million)
• Genomics Instruments Market, By Region 2016 -
  2024 (USD Million)
• Genomics Consumables Market

4

• Your Catalyst To a Lucrative Business
• 4.3.1.1. Genomics Market for Drug Discovery, By
  Region 2016 - 2024 (USD Million)
• Genomics Market for Academic Research
• Genomics Market for Academic Research, 2016 -
  2024 (USD Million)
• Genomics Market for Academic Research, By Region
  2016 - 2024 (USD Million)
• Genomics Market for Agriculture
• Genomics Market for Agriculture, 2016 - 2024
  (USD Million)
• Genomics Market for Agriculture, By Region 2016
  - 2024 (USD Million)
• Chapter 5. Small Interference RNA Market
• siRNA Market Revenue Share, 2016 - 2024
• siRNA Market, 2016 - 2024 (USD Million)
• Chapter 6. Genomics Market Technology Outlook
• Genomics Market Revenue Share by Technology, 2016
  2024
• PCR Based Genomics Market
• PCR Based Genomics Market, 2016 - 2024 (USD
  Million)
• PCR Based Genomics Market, By Region 2016 - 2024
  (USD Million)
• DNA Sequencing Based Genomics Market

5

• Your Catalyst To a Lucrative Business
• 7.5.1. RoW Genomics Market, 2016 - 2024 (USD
  Million)
• Chapter 8. Competitive Landscape
• Affymetrix, Inc.
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Agilent Technologies
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• BGI
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives

6

• Your Catalyst To a Lucrative Business
• Product Benchmarking
• Strategic Initiatives
• Roche Diagnostics
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Life Technologies
• Company Overview
• Product Benchmarking
• Strategic Initiatives
• Cepheid
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Chapter 9. Methodology and Scope

7
Your Catalyst To a Lucrative Business About
Us Hexa Research is a market research and
consulting organization, offering industry
reports, custom research and consulting services
to a host of key industries across the globe. We
offer comprehensive business intelligence in the
form of industry reports which help our clients
obtain clarity about their business environment
and enable them to undertake strategic growth
initiatives. Contact Us Ryan Shaw Hexa
Research Felton Office Plaza 6265 Highway
9 Felton, California 95018 United States Phone
1-800-489-3075 Email sales_at_hexaresearch.com Webs
ite - http//www.hexaresearch.com/ Visit our
Blog https//hexaresearchinc.wordpress.com/